abiraterone,olaparib
astrazeneca,merck
['prostate', 'crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'olaparib', 'propel']
final overall survival (os) in propel by noel clarke, frcs -trend toward os benefit with olaparib+abi in mcrpc!
-olaparib discontinuation 1/5 #gu23 #prostatecancer #medtwitter 
On the road!
Pursuing to improve global health through sharing knowledge, cancer prevention, and care.  
Medical oncologist @AnkaraUni